Archives
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fl...
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1-Modified Red Fluorescent Reporter for Robust Expression
Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic, Cap 1-structured messenger RNA encoding the monomeric red fluorescent protein mCherry, derived from Discosoma sp. Its modifications—including 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP)—reduce innate immune activation and enhance mRNA stability in vitro and in vivo (Guri-Lamce et al., 2024). The Cap 1 structure is enzymatically added, mimicking native mammalian mRNA and maximizing translation efficiency. Provided at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, the product supports robust, precise fluorescent protein expression for molecular and cell biology research. Storage at ≤ -40°C is recommended for optimal activity (ApexBio, 2024).
Biological Rationale
Messenger RNA (mRNA) technology provides a potent platform for transient protein expression in living cells. The mCherry protein, encoded by EZ Cap™ mCherry mRNA (5mCTP, ψUTP), is a monomeric red fluorescent protein with an excitation/emission maximum of 587/610 nm, widely used as a molecular marker (ApexBio, 2024). Native mRNA is inherently unstable and can trigger innate immune responses; chemical modifications such as 5mCTP and ψUTP have been shown to reduce these effects, supporting efficient, robust expression (Guri-Lamce et al., 2024, DOI). The Cap 1 structure further enhances translation by mimicking mammalian mRNA cap methylation. Together, these features make EZ Cap™ mCherry mRNA (5mCTP, ψUTP) a preferred tool for applications demanding reliable, bright, and immune-evasive red fluorescence.
Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) consists of a ~996-nucleotide, in vitro transcribed mRNA encoding mCherry and includes a poly(A) tail for enhanced translation initiation. The Cap 1 structure is enzymatically added using vaccinia virus capping enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2'-O-methyltransferase, ensuring a 2'-O-methylated first nucleotide—key for immune system evasion and efficient translation (ApexBio, 2024). Incorporation of 5mCTP and ψUTP further stabilizes the mRNA by reducing recognition by pattern recognition receptors (PRRs) such as Toll-like receptors (TLR3, TLR7/8), minimizing interferon response (Guri-Lamce et al., 2024). Following delivery (e.g., via lipid nanoparticles or electroporation), the mRNA is translated by host ribosomes, resulting in robust mCherry protein expression for real-time cell tracking and localization studies.
Evidence & Benchmarks
- Lipid nanoparticle (LNP) systems efficiently deliver modified mRNA—including those with Cap 1, 5mCTP, and ψUTP modifications—enabling robust protein expression with minimal immune activation (Guri-Lamce et al., 2024).
- Cap 1-structured mRNA exhibits higher translation efficiency and reduced innate immune stimulation compared to Cap 0 mRNA in mammalian cells (ApexBio, 2024).
- 5mCTP and ψUTP modifications protect mRNA from degradation and extend its half-life in vitro and in vivo, supporting prolonged protein expression (Angiotensin-1-2-5-7.com).
- mCherry’s spectral properties (excitation 587 nm, emission 610 nm) provide clear, quantifiable red fluorescence, facilitating multiplex imaging (abt737.com).
- Storage at or below -40°C maintains mRNA stability and activity for extended periods (ApexBio, 2024).
Applications, Limits & Misconceptions
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is designed for use as a reporter gene in molecular and cell biology research. Key applications include:
- Transient labeling of live cells for tracking, sorting, or imaging studies.
- Assessment of transfection/transduction efficiency in various delivery platforms (e.g., lipid nanoparticles, electroporation).
- Studying cellular localization and protein trafficking using red fluorescent markers.
- Multiplexed assays with other fluorescent proteins for co-localization analysis.
Compared to previous reviews, this article provides additional, up-to-date benchmarks on Cap 1 and nucleotide modification synergy, clarifying the unique role of 5mCTP/ψUTP in immune evasion. For expanded mechanistic context, see the complementary discussion on Angiotensin-1-2-5-7.com, while this dossier enumerates specific parameter ranges and evidence for stability and translation.
Common Pitfalls or Misconceptions
- EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is not suitable for permanent genomic integration; its effects are strictly transient.
- Translation efficiency may vary by cell type and delivery method; optimization is required for each context.
- This mRNA is not intended for direct therapeutic use in humans or animals.
- Improper storage above -40°C may rapidly degrade mRNA and reduce protein expression.
- Fluorescent signal intensity depends on delivery efficiency and cell health; low signal does not always indicate mRNA instability.
Workflow Integration & Parameters
For optimal use, EZ Cap™ mCherry mRNA (5mCTP, ψUTP) should be thawed on ice and diluted with RNase-free buffers. Standard working concentrations range from 10–500 ng/μL, depending on cell type and delivery method. Delivery via lipid nanoparticles (LNPs) or electroporation is recommended for high transfection efficiency (Guri-Lamce et al., 2024). Fluorescence can be detected 4–8 hours post-transfection, with peak protein expression typically observed at 12–48 hours. The mRNA’s poly(A) tail and Cap 1 structure ensure compatibility with mammalian translation machinery. For more on integrating advanced mRNA reporters in complex workflows, see the strategic review at crisprcasy.com, which this article extends by detailing specific buffer conditions and concentration ranges.
Conclusion & Outlook
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) offers a precise, stable, and immune-evasive platform for red fluorescent protein expression in live cells. Its synergistic design—Cap 1 structure plus 5mCTP/ψUTP modifications—delivers robust, reproducible results for molecular imaging, cell tracking, and localization assays. As delivery systems and mRNA engineering evolve, products like this will remain essential tools for both basic and translational research. For full technical details and ordering information, visit the official product page.